News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
706,018 Results
Type
Article (40096)
Company Profile (249)
Press Release (665672)
Multimedia
Podcasts (61)
Webinars (14)
Section
Business (204323)
Career Advice (2011)
Deals (35458)
Drug Delivery (96)
Drug Development (81157)
Employer Resources (172)
FDA (16263)
Job Trends (14894)
News (345584)
Policy (32618)
Tag
Academia (2556)
Accelerated approval (12)
Adcomms (22)
Allergies (98)
Alliances (49570)
ALS (112)
Alzheimer's disease (1483)
Antibody-drug conjugate (ADC) (154)
Approvals (16268)
Artificial intelligence (316)
Autoimmune disease (29)
Automation (20)
Bankruptcy (361)
Best Places to Work (11636)
BIOSECURE Act (19)
Biosimilars (125)
Biotechnology (174)
Bladder cancer (96)
Brain cancer (34)
Breast cancer (381)
Cancer (2962)
Cardiovascular disease (222)
Career advice (1682)
Career pathing (30)
CAR-T (190)
CDC (32)
Cell therapy (512)
Cervical cancer (23)
Clinical research (67013)
Collaboration (1053)
Company closure (3)
Compensation (708)
Complete response letters (26)
COVID-19 (2634)
CRISPR (59)
C-suite (360)
Cystic fibrosis (114)
Data (3162)
Decentralized trials (2)
Denatured (21)
Depression (65)
Diabetes (349)
Diagnostics (6438)
Digital health (23)
Diversity (9)
Diversity, equity & inclusion (45)
Drug discovery (145)
Drug pricing (124)
Drug shortages (28)
Duchenne muscular dystrophy (147)
Earnings (87741)
Editorial (42)
Employer branding (21)
Employer resources (148)
Events (113890)
Executive appointments (860)
FDA (18043)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (951)
Gene editing (134)
Generative AI (23)
Gene therapy (394)
GLP-1 (790)
Government (4520)
Grass and pollen (5)
Guidances (220)
Healthcare (18839)
HIV (40)
Huntington's disease (30)
IgA nephropathy (39)
Immunology and inflammation (155)
Immuno-oncology (9)
Indications (41)
Infectious disease (2814)
Inflammatory bowel disease (151)
Inflation Reduction Act (10)
Influenza (69)
Intellectual property (125)
Interviews (312)
IPO (16593)
IRA (46)
Job creations (3637)
Job search strategy (1424)
Kidney cancer (13)
Labor market (55)
Layoffs (501)
Leadership (19)
Legal (7931)
Liver cancer (79)
Longevity (11)
Lung cancer (414)
Lymphoma (217)
Machine learning (12)
Management (58)
Manufacturing (417)
MASH (94)
Medical device (13480)
Medtech (13486)
Mergers & acquisitions (19606)
Metabolic disorders (857)
Multiple sclerosis (100)
NASH (16)
Neurodegenerative disease (134)
Neuropsychiatric disorders (35)
Neuroscience (2194)
NextGen: Class of 2025 (6517)
Non-profit (4489)
Now hiring (50)
Obesity (429)
Opinion (218)
Ovarian cancer (103)
Pain (113)
Pancreatic cancer (128)
Parkinson's disease (189)
Partnered (22)
Patents (319)
Patient recruitment (178)
Peanut (50)
People (57757)
Pharmaceutical (63)
Pharmacy benefit managers (21)
Phase I (20866)
Phase II (29520)
Phase III (21978)
Pipeline (1718)
Policy (205)
Postmarket research (2564)
Preclinical (8892)
Press Release (64)
Prostate cancer (144)
Psychedelics (37)
Radiopharmaceuticals (253)
Rare diseases (472)
Real estate (5917)
Recruiting (66)
Regulatory (22765)
Reports (50)
Research institute (2328)
Resumes & cover letters (350)
Rett syndrome (9)
RNA editing (9)
RSV (52)
Schizophrenia (91)
Series A (158)
Series B (110)
Service/supplier (11)
Sickle cell disease (62)
Special edition (18)
Spinal muscular atrophy (148)
Sponsored (32)
Startups (3590)
State (2)
Stomach cancer (14)
Supply chain (78)
Tariffs (61)
The Weekly (38)
Vaccines (798)
Venture capital (56)
Weight loss (258)
Women's health (47)
Worklife (16)
Date
Today (97)
Last 7 days (526)
Last 30 days (1772)
Last 365 days (30932)
2025 (17911)
2024 (35218)
2023 (40076)
2022 (51177)
2021 (55710)
2020 (54083)
2019 (46538)
2018 (35019)
2017 (32108)
2016 (31481)
2015 (37552)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (723)
Alabama (63)
Alaska (7)
Arizona (244)
Arkansas (13)
Asia (38265)
Australia (6244)
California (7655)
Canada (2427)
China (685)
Colorado (322)
Connecticut (326)
Delaware (201)
Europe (82276)
Florida (1159)
Georgia (258)
Hawaii (2)
Idaho (60)
Illinois (653)
India (28)
Indiana (370)
Iowa (17)
Japan (238)
Kansas (110)
Kentucky (30)
Louisiana (15)
Maine (64)
Maryland (1051)
Massachusetts (5696)
Michigan (250)
Minnesota (466)
Mississippi (4)
Missouri (95)
Montana (28)
Nebraska (25)
Nevada (85)
New Hampshire (67)
New Jersey (2133)
New Mexico (28)
New York (2132)
North Carolina (1098)
North Dakota (8)
Northern California (3394)
Ohio (242)
Oklahoma (16)
Oregon (34)
Pennsylvania (1664)
Puerto Rico (17)
Rhode Island (37)
South America (1098)
South Carolina (34)
South Dakota (1)
Southern California (2879)
Tennessee (128)
Texas (1168)
United States (28343)
Utah (222)
Virginia (192)
Washington D.C. (72)
Washington State (647)
West Virginia (4)
Wisconsin (67)
706,018 Results for "diamedica inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
DiaMedica Therapeutics Announces Inclusion in the Russell 2000® and Russell 3000® Indexes
June 24, 2025
·
2 min read
Press Releases
DiaMedica Therapeutics Announces Closing of $30.1 Million Private Placement
July 24, 2025
·
9 min read
Press Releases
DiaMedica Therapeutics Raises $30 Million in Private Placement to Accelerate Industry Leading Preeclampsia and Fetal Growth Restriction Pipeline
July 22, 2025
·
7 min read
Press Releases
DiaMedica Therapeutics Reports Positive Interim Phase 2 Preeclampsia Results: Statistically Significant Reductions in Blood Pressure and No Placental Transfer
July 17, 2025
·
11 min read
Press Releases
DiaMedica Therapeutics to Present at Jefferies Global Healthcare Conference 2025
May 22, 2025
·
1 min read
Press Releases
DiaMedica Therapeutics to Participate in Upcoming Investor Conferences in May
May 8, 2025
·
1 min read
Press Releases
DiaMedica Therapeutics Announces Poster Presentation at European Stroke Organisation Conference – ESOC 2025
May 14, 2025
·
1 min read
Press Releases
DiaMedica Therapeutics Reports First Quarter 2025 Financial Results And Provides Business Highlights
May 13, 2025
·
15 min read
Press Releases
DiaMedica Therapeutics Announces Key Opinion Leader Webinar on DM199 (Rinvecalinase Alfa) for the Treatment of Preeclampsia
May 19, 2025
·
6 min read
Press Releases
DiaMedica Therapeutics to Report First Quarter 2025 Financial Results and Provide a Business Update May 14, 2025
May 7, 2025
·
1 min read
1 of 70,602
Next
